Skip to main content
Year archive

MAYNE PHARMA GROUP LIMITED — 2016 filings

All 80 regulatory filings released by MAYNE PHARMA GROUP LIMITED (MYX) in 2016, sourced directly from the official regulator.

80 Filings
2016 Period
2016 filings (80)
Filing Released Lang
Change of Director's Interest Notice 2 pages 42.4KB
Director's Dealing
2016-12-27 English
Appendix 3B 9 pages 329.0KB
Capital/Financing Update
2016-12-27 English
Appendix 3B 9 pages 722.0KB
Capital/Financing Update
2016-12-20 English
Change of Director's Interest Notice (x4) 8 pages 2.0MB
Director's Dealing
2016-12-20 English
Change of Director's Interest Notices (x2) 4 pages 1.2MB
Director's Dealing
2016-12-18 English
Update on Status of DOJ Investigation 1 page 232.8K
Legal Proceedings Report
2016-12-15 English
Appendix 3B 9 pages 722.6KB
Share Issue/Capital Change
2016-12-12 English
Ceasing to be a substantial holder from NAB 15 pages 185.3KB
Major Shareholding Notification
2016-12-11 English
Change of Director's Interest Notice 2 pages 49.6KB
Director's Dealing
2016-12-11 English
Change in substantial holding 3 pages 74.9KB
Major Shareholding Notification
2016-12-11 English
Appendix 3B 9 pages 330.1KB
Capital/Financing Update
2016-12-08 English
Change of Director's Interest Notice 2 pages 41.9KB
Director's Dealing
2016-12-06 English
Becoming a substantial holder from NAB 25 pages 553.9KB
Major Shareholding Notification
2016-11-29 English
2016 AGM Chairman's Speech 4 pages 184.8KB
AGM Information
2016-11-28 English
2016 AGM CEO's Speech 6 pages 211.3KB
AGM Information
2016-11-28 English
Results of Annual General Meeting 2 pages 245.5KB
Declaration of Voting Results & Voting Rights Announcements
2016-11-28 English
IDT:Mayne Pharma Announces U.S. Launch of IDT's Temozolomide 2 pages 539.6KB
Regulatory Filings
2016-11-21 English
UBS Australasia Conference Presentation 16 pages 1.5MB
Investor Presentation
2016-11-06 English
Update on Status of DOJ Investigation 1 page 98.2KB
Legal Proceedings Report
2016-11-03 English
MYX launches generic MS Contin (morphine sulfate) tablets 1
Regulatory Filings
2016-11-02 English
MYX launches generic Entocort EC (Budesonide) capsules 1
Regulatory Filings
2016-10-26 English
Notice of Annual General Meeting/Proxy Form 10 pages 2.7MB
AGM Information
2016-10-16 English
Appendix 3B 9 pages 492.0KB
Capital/Financing Update
2016-10-10 English
2016 Annual Report 88 pages 3.1MB
Annual Report
2016-10-06 English
2016 Corporate Governance Statement 17 pages 401.0KB
Governance Information
2016-10-06 English
Appendix 4G 13 pages 302.8KB
Governance Information
2016-10-06 English
Appendix 3B 9 pages 464.6KB
Share Issue/Capital Change
2016-09-28 English
Ceasing to be a substantial holder from WBC 8 pages 296.5KB
Major Shareholding Notification
2016-09-27 English
Appendix 3B 9 pages 466.2KB
Share Issue/Capital Change
2016-09-25 English
Initial Director's Interest Notice 2 pages 93.3KB
Director's Dealing
2016-09-22 English
Change of Director's Interest Notice 2 pages 107.0KB
Director's Dealing
2016-09-22 English
Mayne Pharma appoints new Board member 1 page 186.0
Board/Management Information
2016-09-20 English
Change of Director's Interest Notice 2 pages 383.5KB
Director's Dealing
2016-09-12 English
Change in substantial holding from WBC 17 pages 524.9KB
Major Shareholding Notification
2016-08-31 English
Appendix 4E, Directors Report and Financial Statements 70 pages 1.6MB
Annual Report
2016-08-25 English
2016 Full Year Results Media Release 4 pages 236.0KB
Annual Report
2016-08-25 English
2016 Full Year Results Investor Presentation 19 pages 1.2MB
Investor Presentation
2016-08-25 English
Appendix 3B 9 pages 465.7KB
Capital/Financing Update
2016-08-24 English
Appendix 3B 9 pages 464.9KB
Share Issue/Capital Change
2016-08-21 English
Response to ASX Appendix 3Y Query 3 pages 740.0KB
Director's Dealing
2016-08-18 English
MYX announces acquisition of US foam dermatology assets 2 pages 137.9KB
Capital/Financing Update
2016-08-17 English
Investor Presentation Acquisition of GSK Foam Assets 10 pages 853.5KB
Capital/Financing Update
2016-08-17 English
Change of Director's Interest Notice 2 pages 307.2KB
Director's Dealing
2016-08-15 English
Appendix 3B 9 pages 464.5KB
Share Issue/Capital Change
2016-08-10 English
Appendix 3B 9 pages 464.2KB
Share Issue/Capital Change
2016-08-03 English
Completion of US generic product acquisition from Teva 1
Capital/Financing Update
2016-08-02 English
MYX announces settlement from patent infringement case 1
Legal Proceedings Report
2016-07-28 English
Change of Director's Interest Notice 2 pages 423.5KB
Director's Dealing
2016-07-26 English
Change in substantial holding from WBC 47 pages 1.1MB
Major Shareholding Notification
2016-07-26 English
Ceasing to be a substantial holder from BTT 6 pages 116.6KB
Major Shareholding Notification
2016-07-25 English
Appendix 3B 9 pages 355.8KB
Capital/Financing Update
2016-07-21 English
Change in substantial holding from BTT 15 pages 202.4KB
Major Shareholding Notification
2016-07-20 English
Retail Entitlement Offer completion and scale back policy 1
Capital/Financing Update
2016-07-19 English
Change to option exercise price and Appendix 3B 11 pages 930.3KB
Share Issue/Capital Change
2016-07-14 English
Change of Director's Interest Notice 2 pages 383.8KB
Director's Dealing
2016-07-12 English
Section 708A notice 1 page 303.8KB
Capital/Financing Update
2016-07-06 English
Change of Director's Interest Notices (x5) 10 pages 944.5KB
Director's Dealing
2016-07-06 English
ASX Notice - Accelerated Non Renounceable Entitlement Offer 2 pages 365.4KB
Capital/Financing Update
2016-07-05 English
Dispatch Retail Offer Booklet and ineligible letter 3 pages 407.7KB
Capital/Financing Update
2016-07-04 English
Completion institutional entitlement offer and placement 2 pages 285.3KB
Capital/Financing Update
2016-06-29 English
Retail Offer Booklet 59 pages 7.1MB
Share Issue/Capital Change
2016-06-29 English
Trading Halt 2 pages 476.3KB
Capital/Financing Update
2016-06-27 English
MYX announces acquisition of US generic product portfolio 8 pages 184.6KB
Capital/Financing Update
2016-06-27 English
Appendix 3B 9 pages 253.7KB
Capital/Financing Update
2016-06-27 English
Section 708A notice 2 pages 327.0KB
Capital/Financing Update
2016-06-27 English
Investor Presentation Acquisition of US generic portfolio 40 pages 2.1MB
Investor Presentation
2016-06-27 English
MYX receives first generic approval of Tikosyn capsules 2 pages 203.9KB
Capital/Financing Update
2016-06-06 English
Wilson HTM Rapid Insights Conference Presentation 11 pages 1.2MB
Investor Presentation
2016-06-01 English
Change in substantial holding from BTT 13 pages 295.0KB
Major Shareholding Notification
2016-05-31 English
Mayne Pharma receives FDA approval for Doryx MPC tablets 2 pages 161.2KB
Regulatory Filings
2016-05-22 English
Appendix 3B 9 pages 334.9KB
Capital/Financing Update
2016-04-21 English
Appendix 3B and lapse of employee options 10 pages 902.4KB
Capital/Financing Update
2016-04-04 English
Appendix 3B 9 pages 425.3KB
Share Issue/Capital Change
2016-03-06 English
Appendix 3B and ASIC Form 484 11 pages 594.4KB
Regulatory Filings
2016-02-28 English
Ceasing to be a substantial holder 3 pages 97.4KB
Regulatory Filings
2016-02-25 English
Half Yearly Report and Accounts 30 pages 953.3KB
Interim / Quarterly Report
2016-02-25 English
2016 Half Year Media Release 4 pages 228.7KB
Interim / Quarterly Report
2016-02-25 English
2016 Half Year Investor Presentation 18 pages 1.3MB
Interim / Quarterly Report
2016-02-25 English
Becoming a substantial holder 14 pages 824.0KB
Regulatory Filings
2016-02-21 English
Appendix 3B 9 pages 469.6KB
Share Issue/Capital Change
2016-01-18 English